Rare diseases
Investigational molecules
Locations
Via Pietro Albertoni 15, 40138 Bologna, Italy
Clinical research includes care for decompensated cirrhosis, with attention to long-term albumin treatment and the safety of alternative albumin formulations in advanced liver disease.
The sponsor also studies unresectable hepatocellular carcinoma, including patients with early progression after first-line systemic treatment.
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico runs clinical trials in conditions such as Vulval cancer recurrent, Hepatocellular carcinoma, Hepatic cirrhosis, Neuromyelitis optica spectrum disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyItalyStudy on Electrochemotherapy with Carboplatin and Bleomycin for Women with Relapsed Vulvar Cancer After Multiple Treatments
ItalyStudy of Fecal Microbiota Transplantation combined with atezolizumab and bevacizumab in patients with unresectable liver cancer who progressed after initial treatment
ItalyStudy on the Safety and Effectiveness of Human Plasma Proteins and Glutathione for Patients with Decompensated Cirrhosis
ItalySafety and dose‑finding study of CD19‑CART01 in patients with SLE, SSc, DM/PM, IMNM, AAV, MG, NMOSD, or chronic GVHD
ItalyTargeted peri‑operative prophylaxis using eravacycline (drug combination) versus standard prophylaxis in liver transplant patients colonized with CPE
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
